Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Operating Margin (2024 - 2025)

Beta Bionics' Operating Margin history spans 2 years, with the latest figure at 50.2% for Q4 2025.

  • For Q4 2025, Operating Margin rose 1358.0% year-over-year to 50.2%; the TTM value through Dec 2025 reached 71.5%, down 202.0%, while the annual FY2025 figure was 71.5%, 202.0% down from the prior year.
  • Operating Margin for Q4 2025 was 50.2% at Beta Bionics, up from 62.54% in the prior quarter.
  • Across five years, Operating Margin topped out at 50.2% in Q4 2025 and bottomed at 105.69% in Q1 2025.